S Hackett - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S Hackett

Showing results (141-150 of 143) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 143 results.

ACS Medicinal Chemistry Letters|December 18, 2024

Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.

The New England Journal of Medicine|April 20, 2000

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.

Clinical and Experimental Immunology|July 12, 2013

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012J D M Edgar, M Buckland, D Guzman, et al.

Pageof 15

Search research articles

Showing results (141-150 of 143) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 143 results.

ACS Medicinal Chemistry Letters|December 18, 2024

Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.

The New England Journal of Medicine|April 20, 2000

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.

Clinical and Experimental Immunology|July 12, 2013

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012J D M Edgar, M Buckland, D Guzman, et al.

Pageof 15